Fevertree Drinks retained Jefferies' 'buy' rating and 1,100p price target after first-half results showed stronger US growth and better earnings prospects. US revenue grew 11% at constant currency, driven by expanded distribution and marketing through its Molson Coors partnership. First-half sales and adjusted EBITDA slightly exceeded forecasts, prompting Jefferies to raise EPS estimates for 2026 and 2027. The broker expects continued US growth and margin improvement from local production and product diversification beyond tonic drinks.
Lazard has appointed Daniel Burton-Morgan as Managing Director and Head of Equity Capital Markets Advisory for North America, enhancing its advisory services in equity capital markets. Based in New York, Burton-Morgan will advise clients on IPOs, fol...
Microsoft's stock has fallen from its highs amid a market shift away from big tech, even as Azure surpassed $100 billion in annual revenue and AI-related services show rapid growth. The company reported strong fundamentals, including 45% projected Az...
Exiger, a leading supply chain AI company, has launched 1Exiger, an AI-native platform that enhances supply chain, procurement, and compliance tasks through autonomous agentic AI capabilities. Backed by a $1.2 billion investment and strategic acquisi...
Vision Lithium Inc. has entered an option agreement with Osisko Metals, granting Osisko the exclusive right to acquire full ownership of the Red Brook Property, covering about 3,982 hectares in New Brunswick. Osisko must make staged cash payments tot...
CollPlant Biotechnologies has acquired LightSolver Ltd., a pioneer in photonic computing with its Laser Processing Unit (LPU) technology. This acquisition diversifies CollPlant's portfolio into advanced photonic computing, targeting high-demand secto...
